GlassScriptPhysician profile
Douglas Pacaccio
NPI 1013005867
$4,148,110.22
in general payments reported to CMS, 2019-2025
37 companies · $104K in 2025
The $104K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $64K · 2021: $3.6M · 2022: $73K · 2023: $73K · 2024: $127K · 2025: $104K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $249K · Travel and Lodging: $29K · Food and Beverage: $15K · Royalty Or License: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $249,080.46 |
| Travel and Lodging | $28,690.29 |
| Food and Beverage | $15,142.40 |
| Royalty Or License | $10,922.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $3,649,480.52 | 2021-2025 | Dynanail, Dynanail Helix, Washer, 15 Mm, Dynanail Mini |
| Stryker Corporation | $387,051.77 | 2019-2025 | Hoffmann, Prostep, Ortholoc 2 Lapifuse |
| Merete Technologies, INC | $73,322.88 | 2019-2025 | |
| Fusion Orthopedics USA, LLC | $13,403.16 | 2024-2025 | Lapilock |
| Restor3d, INC. | $7,942.88 | 2024-2025 | |
| Trilliant Surgical LLC. | $7,133.64 | 2021-2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate |
| Biotissue Holdings INC. | $1,945.86 | 2020-2023 | |
| Paragon 28, INC. | $1,505.50 | 2022 | |
| Artivion, INC. | $1,312.50 | 2019 | |
| Surgenex LLC | $758.27 | 2025 | Renograft, Surmatrix, Ardeograft |
| Kerecis Limited | $710.81 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Orthofix Medical, INC. | $476.71 | 2022-2025 | Physio-Stim, Accelstim |
| Medline Industries LP | $436.04 | 2025 | |
| Linvatec Corporation | $377.11 | 2024-2025 | Neospan, Biobrace 23mm, Fracture and Correction Colag 2 |
| Bone Support INC. | $325.41 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $291.16 | 2025 | Nexis |
| Acera Surgical, INC. | $284.66 | 2019-2024 | Restrata Wound Matrix |
| Treace Medical Concepts, INC. | $225.84 | 2025 | |
| Rmr Ortho INC | $159.06 | 2025 | A'Tomic |
| Amniox Medical, INC. | $111.74 | 2020 | |
| Imbed Biosciences INC. | $107.25 | 2023 | |
| Encore Medical, LP | $102.19 | 2021 | |
| Oxford Performance Materials, INC. | $100.00 | 2025 | |
| Bonalive INC | $79.99 | 2024-2025 | |
| Axogen | $76.34 | 2019-2025 | Axoguard Ha+ Nerve Protector |
| Integra Lifesciences Corporation | $67.05 | 2019-2020 | |
| Sanara Medtech INC. | $58.05 | 2020-2021 | |
| Melinta Therapeutics, LLC | $46.55 | 2019 | |
| Djo, LLC | $37.24 | 2025 | Cmf |
| Vertex Pharmaceuticals Incorporated | $35.34 | 2025 | |
| Paratek Pharmaceuticals, INC. | $33.91 | 2023-2024 | Nuzyra |
| Medela LLC | $25.61 | 2020 | |
| Mimedx Group, INC. | $24.29 | 2024 | |
| Janssen Pharmaceuticals, INC | $20.98 | 2021 | |
| Osteomed LLC | $14.02 | 2020 | |
| Innovation Technologies INC | $13.20 | 2024 | Irrisept |
| Wright Medical Technology, INC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,355,036.32 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Pacaccio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.